---
title: "Belite Bio CMO Hendrik Peter Scholl reports disposal of ADS worth $1.46 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290417210.md"
description: "Belite Bio disclosed that Chief Medical Officer Hendrik Peter Scholl sold 10,000 American depositary shares (ADS) on June 18, 2026. The transaction value was approximately $1.46 million, with prices ranging from USD 143.90 to USD 147.11 per share. These holdings were reported indirectly through Bioptima Ltd., which now holds 15,000 ADS following the sale."
datetime: "2026-06-22T10:06:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290417210.md)
  - [en](https://longbridge.com/en/news/290417210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290417210.md)
generator: "portal-rs"
---

# Belite Bio CMO Hendrik Peter Scholl reports disposal of ADS worth $1.46 million

-   Belite Bio disclosed sales of 9,? shares by Chief Medical Officer Hendrik Peter Scholl on June 18, 2026. \* The transactions covered 10,000 American depositary shares sold at prices ranging from USD 143.90 to USD 147.11. \* Holdings reported indirectly through Bioptima Ltd. fell to 15,000 American depositary shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-276615), on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BLTE.US](https://longbridge.com/en/quote/BLTE.US.md)

## Related News & Research

- [Belite Bio to present Phase 3 DRAGON tinlarebant results in Stargardt disease at SOG congress](https://longbridge.com/en/news/296615069.md)
- [Belite Bio to Host Virtual Commercial Day on September 2, 2026 | BLTE Stock News](https://longbridge.com/en/news/296824258.md)
- [XCharge plans 1-for-20 reverse ADS split via ratio change effective Aug. 21](https://longbridge.com/en/news/296347969.md)
- [Zai Lab CFO Chen Yajing sells 260 ADS worth $7,020](https://longbridge.com/en/news/296649594.md)
- [Adagene director Cuong Do reports purchase of ADS worth $7,500](https://longbridge.com/en/news/296274597.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**